Nikolay A. Mukhin
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Prediction of features of the course of chronic hepatitis C using Bayesian networks.
Journal: Terapevticheskii arkhiv
Published: May 17, 2019
Clinical significance of the determination of surfactant proteins A and D in assessing the activity of lung sarcoidosis.
Journal: Terapevticheskii arkhiv
Published: February 01, 2019
Role of neutrophil dysfunction in the pathogenesis of systemic lupus erythematosus
Journal: Terapevticheskii arkhiv
Published: February 08, 2018
Genetic and clinical data predict onset of cryoglobulinemia in HCV patients and cryoglobulins clearance.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 08, 2017
Giant cell arteritis: Genetic and epigenetic aspects
Journal: Terapevticheskii arkhiv
Published: September 16, 2017
Autoinflammatory diseases and kidney involvement
Journal: Terapevticheskii arkhiv
Published: July 27, 2017
Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment
Journal: Terapevticheskii arkhiv
Published: June 21, 2017
EVALUATION OF CARDIOVASCULAR RISKS WITH THE USE OF MORPHOGENETIC KLOTHO PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASE
Journal: Klinicheskaia meditsina
Published: January 01, 2017
Persistent hepatitis C virus-associated cryoglobulinemic vasculitis following virus eradication after direct-acting antiviral therapy.
Journal: Hepatology (Baltimore, Md.)
Published: October 14, 2016
HCV-associated cryoglobulinemia vasculitis: are its days numbered?
Journal: Annals of the rheumatic diseases
Published: October 04, 2016
Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis C
Journal: Terapevticheskii arkhiv
Published: September 17, 2016
Letter: cure of chronic hepatitis B and D after 12 years of treatment with low-dose standard interferon alfa-2b.
Journal: Alimentary pharmacology & therapeutics
Published: August 12, 2016
Last Updated: 09/26/2026